Intégralité de la lettre demandant à la Commission de refuser la fusion
Voici l’intégralité de la lettre (version anglaise) adressée hier à la Commissaire à la Concurrence Mme Vestager, dans laquelle Eric Andrieu et 54 députés européens demandent à la Commission européenne de refuser l’acquisition de Monsanto par Bayer comme la Commission est habilitée de le faire.
22 September 2016
MEP Michèle Rivasi
Bât. Altiero Spinelli
60, rue Wiertz 1047, Brussels
Commissioner Margrethe Vestager European
Commission Rue de la Loi 1049 Brussels
Subject: Bayer-Monsanto merger
Dear Commissioner Margrethe Vestager,
On Wednesday 14th September 2016 the German pharmaceutical group Bayer has finally announced it will buy the American seed-maker Monsanto for 59 billion euros. As it is enshrined in article 2 of Regulation 139/2004, takeovers of this kind are prohibited if they contribute to significantly reduce competition in the single market by strengthening a dominant position. The combined aggregate worldwide turnover of Monsanto and Bayer is far beyond the threshold of 5 billion euros foreseen in the aforementioned Regulation that allows the Commission to trigger an investigation since their turnovers put together amount for 23 billion euros. Moreover, the aggregate Community-wide turnover of each is more than 250 million euros and these two firms are partly operating in the same markets such as the seeds and pesticides’ markets.
In February 2013, a report entitled Seed Giants vs US Farmers by Center for Food Safety had already showed that the increase in seed prices resulted from the seed industry concentration. If this takeover were effectively to take place, Bayer could control 30% of the seed world market and 24% of the pesticide world market (1). This is what we can call, strengthening a « dominant position ». Through this operation, Bayer will achieve unprecedented global market dominance in this sensitive area and benefit from an unbearable influence that will threaten the way we feed ourselves as much as our access to affordable medical treatments. Since more and more European citizens are becoming aware that it is now urgent to shift towards a sustainable agricultural model, this takeover will go against their will.
While many patients are complaining about the opacity and the prices of some medicines sold by big pharmaceuticals like Bayer, this acquisition will strengthen this tendency. This takeover will go against the principles that matter to us: a vital democracy in which our environment and our health are effectively protected. The Commission is entitled by the European legislation to open an investigation (2) and ultimately reject such dangerous deals. Therefore, we ask you, Commissioner Margrethe Vestager, to prohibit the acquisition of Monsanto by Bayer.
Michèle Rivasi, Vice-President of the Greens / EFA group
With: Marco Affronte, Eric Andrieu, Maria Arena, Paloma López Bermejo, Guillaume Balas, Tiziana Beghin, David Borrelli, José Bové, Klaus Buchner, Nicola Caputo, Fabio Castaldo, Nessa Childers, Karima Delli, Anneliese Dodds, Pascal Durand, Bas Eickhout, Eleonora Evi, Sven Giegold, Tania Gonzalez, Rebecca Harms, Martin Häusling, Maria Heubuch, Le Hyaric Patrick, Yannick Jadot, Benedek Jávor, Eva Joly, Dennis de Jong, Kateřina Konečná, Philippe Lamberts, Barbara Lochbihler, Ulrike Lunacek, Ernest Maragall, Fabio De Masi, Jean-Luc Mélenchon, Anne-Marie Mineur, Maria Noichl, Younous Omarjee, Maite Pagazaurtundúa Piernicola Pedicini, Michel Reimon, Terry Reintke, Virginie Rozière, Molly Scott, Cato Lidia, Senra Rodríguez, Bart Staes, Dario Tamburrano, Josep Maria Terricabras, Estefanía Torres Martínez, Claude Turmes, Enest Urtasun, Monika Vana, Marco Valli, Marie-Christine Vergiat, Marco Zullo.
(2) As you promised in a letter sent to MEPs on June 2016: http://www.sven-giegold.de/wp-content/uploads/2016/06/Vestager-Antwort_Bayer-Monsanto.pdf